Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Review ArticleReview

Digital Reference Materials: A New Standard for Quality and Compliance in Bio/Pharmaceutical Manufacturing

Vadim Klyushnichenko
PDA Journal of Pharmaceutical Science and Technology November 2025, 79 (6) 682-685; DOI: https://doi.org/10.5731/pdajpst.2025-000039.1
Vadim Klyushnichenko
Calibr-Skaggs Institute for Innovative Medicines, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vklyushnichenko{at}scripps.edu
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

As biopharmaceutical manufacturing evolves toward digitalization, the need for structured, interoperable, and regulatory-compliant data is intensifying. Digital reference materials (dRMs), the machine-readable counterparts of physical reference standards, have emerged as critical tools for enhancing data integrity, enabling automated quality control, and supporting regulatory transparency. This article explores the definition, structure, and implementation of dRMs within the pharmaceutical landscape. It examines regulatory initiatives such as the U.S. Food and Drug Administration’s eCTD 4.0 and KASA, pharmacopeial digitization efforts, and pioneering commercial applications like Merck/MilliporeSigma’s ChemisTwin™. Technical foundations, such as XML, JSON, and AnIML formats, are discussed alongside their integration into laboratory systems such as LIMS, ELNs, and CDS platforms. Special attention is given to the challenges of implementing dRMs in chromatography, where method-specific variability complicates standardization. Ultimately, dRMs are positioned as enablers of intelligent manufacturing, supporting AI-driven analytics, digital twins, and harmonized global quality systems. This work underscores the strategic imperative for stakeholders to invest in digital infrastructure, standards, and collaboration to fully realize the potential of digital reference materials in modern pharmaceutical development.

  • © PDA, Inc. 2025
View Full Text

PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

Full issue PDFs are for PDA members only.

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 6
November/December 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Digital Reference Materials: A New Standard for Quality and Compliance in Bio/Pharmaceutical Manufacturing
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Digital Reference Materials: A New Standard for Quality and Compliance in Bio/Pharmaceutical Manufacturing
Vadim Klyushnichenko
PDA Journal of Pharmaceutical Science and Technology Nov 2025, 79 (6) 682-685; DOI: 10.5731/pdajpst.2025-000039.1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Digital Reference Materials: A New Standard for Quality and Compliance in Bio/Pharmaceutical Manufacturing
Vadim Klyushnichenko
PDA Journal of Pharmaceutical Science and Technology Nov 2025, 79 (6) 682-685; DOI: 10.5731/pdajpst.2025-000039.1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction and Definition of Digital Reference Materials
    • Regulatory and Nonprofit Initiatives Supporting dRM
    • Industry Implementation
    • Technological Foundations and Future Directions
    • Conclusion
    • References
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Overcoming device component-related challenges and risks in prefilled syringe development
  • Ode to a Sporicide - Can we do better?
  • The European Qualified Person: Legal Accountability, Quality Leadership, and AI Integration in Modern Pharmaceutical Manufacturing
Show more Review

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2026 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire